Structural changes affecting the skin, muscles, ligaments, fat, and bone get noticeable on an individual’s face due to decrease in cellular functions with aging. The inevitable physiological process of aging is generally not conceived positively by many, which, in turn, urges them to indulge in cosmetic rejuvenation procedures to remain youthful visually. Botulinum toxin (BOTA) is the most popular neurotoxin used in cosmetic procedures. The BOTA selection to treat the aforementioned case involved Abobotulinum A (ABO; Dysport/Ipsen Limited, Slough Berkshire, UK) containing 500 European units. Following the manufacturer’s recommended ratio of 2.5 ml saline solution to 500 units botulinum toxin was administered, the reconstitution was carried out. Therefore, the rising popularity of cosmetic procedures involving neurotoxins to reduce facial wrinkles while ensuring safety, effectivity, and efficiency is catalyzing the market for neurotoxins.
The Europe neurotoxin market has been segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and the Rest of Europe. The surging geriatric population, rising product launches, increasing distribution of neurotoxin products, and growing government regulations for non-surgical aesthetic products and procedures will likely enhance the market growth. Also, rising numbers of aesthetic clinics may offer vital growth opportunities for market growth. In the UK, there was no industry to regulate the standards for non-surgical procedures. Also, there was no need for a legal license to perform Botox or filler injections procedures. Thus, these were the leading factors that defined the growth of the neurotoxin market in the past few years across the country. However, in 2013, Health Education England developed standards and qualifications frameworks for practitioners' failings to improve public protection and to reduce risks that may cause severe side effects of aesthetic procedures.
Europe Neurotoxins Market Segmentation
The Europe neurotoxins market is segmented into product type, application, end user, and country.
Based on product type, the Europe neurotoxins market is subsegmented into botox, dysport, xenomin, and others, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.
Based on application, the Europe neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.
Based on end user, the market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.
Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and the Rest of Europe. Germany dominated the market share in 2023.
AbbVie Inc, Evolus Inc, Hugel Inc, Ipsen SA, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the Europe neurotoxins market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 1,174.94 Million |
| Market Size by 2028 | US$ 2,038.94 Million |
| CAGR (2022 - 2028) | 11.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Product Type
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Neurotoxins Market is valued at US$ 1,174.94 Million in 2023, it is projected to reach US$ 2,038.94 Million by 2028.
As per our report Europe Neurotoxins Market, the market size is valued at US$ 1,174.94 Million in 2023, projecting it to reach US$ 2,038.94 Million by 2028. This translates to a CAGR of approximately 11.7% during the forecast period.
The Europe Neurotoxins Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Neurotoxins Market report:
The Europe Neurotoxins Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Neurotoxins Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Neurotoxins Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)